Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Molecular Pharmacology|January 10, 2006
Identification and characterization of compounds that potentiate NT-3-mediated Trk receptor activityMartin A Lewis, Lisa Hunihan, Diana Franco, et al.Bioorganic & Medicinal Chemistry Letters|April 18, 2002
Oxime derivatives of sordaricin as potent antifungal agentsMichael H Serrano-Wu, Denis R St Laurent, Charles E Mazzucco, et al.Journal of Medicinal Chemistry|March 14, 2014
Discovery and development of hepatitis C virus NS5A replication complex inhibitorsMakonen Belema, Omar D Lopez, John A Bender, et al.Organic Letters|March 25, 2005
Novel 3',6'-anhydro and N12,N13-bridged glycosylated fluoroindolo[2,3-a]carbazoles as topoisomerase I inhibitors. Fluorine as a leaving group from sp3 carbonMark G Saulnier, David R Langley, David B Frennesson, et al.Bioorganic & Medicinal Chemistry Letters|September 10, 2002
Sordarin oxazepine derivatives as potent antifungal agentsMichael H Serrano-Wu, Denis R St Laurent, Yijun Chen, et al.Journal of Virology|October 9, 2009
Identification of hepatitis C virus NS5A inhibitorsJulie A Lemm, Donald O'Boyle, Mengping Liu, et al.ACS Medicinal Chemistry Letters|June 6, 2014
Inhibitors of HCV NS5A: From Iminothiazolidinones to Symmetrical StilbenesJeffrey L Romine, Denis R St Laurent, John E Leet, et al.Virology|July 31, 2013
Characterizations of HCV NS5A replication complex inhibitorsDonald R O'Boyle Ii, Jin-Hua Sun, Peter T Nower, et al.Bioorganic & Medicinal Chemistry Letters|April 2, 2003
Identification of a broad-spectrum azasordarin with improved pharmacokinetic propertiesMichael H Serrano-Wu, Denis R St Laurent, Tina M Carroll, et al.Bioorganic & Medicinal Chemistry Letters|June 28, 2013
HCV NS5A replication complex inhibitors. Part 5: discovery of potent and pan-genotypic glycinamide cap derivativesMakonen Belema, Van N Nguyen, Denis R St Laurent, et al.Pageof 2